PapersPMID:29509641
Caffeine, CYP1A2 Genotype, and Endurance Performance in Athletes.
- 01 · finding
- 1
- 02 · compound
- 1
- 03 · endpoint
- 1
- 04 · null
- 0
caffeineWhat moved
1 findingHow to read these marks →caffeine — decreases time-trial completion time
very limitedFindingreplicated ×5
“Overall, 4 mg·kg caffeine decreased cycling time by 3% (mean ± SEM) versus placebo (17.6 ± 0.1 vs 18.1 ± 0.1 min, P = 0.01).”
Quoted verbatim from Caffeine, CYP1A2 Genotype, and Endurance Performance in Athletes. - Study
- crossover
- Participants
- 101
- Dose studied
- 4 mg/kg caffeine, single dose
- Population
- competitive male athletes, whole cohort pooled across CYP1A2 genotypes, 10-km cycling time trial
Study record
- Read under
- caffeine
- Design
- crossover trial
- Species
- human
- Population
- 101 competitive male athletes, genotyped for CYP1A2 -163A>C (rs762551)
- Participants
- 101
- Comparator
- another dose / placebo
- Duration
- not recorded
- Endpoints measured
- 4
- Record
- extracted
- Readings recorded
- 2